We are live on ! Find out more
LAB icon

Standard BioTools
LAB

79 hedge funds and large institutions have $291M invested in Standard BioTools in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 23

35% more call options, than puts

Call options by funds: $1.41M | Put options by funds: $1.04M

28% more capital invested

Capital invested by funds: $227M → $291M (+$64.3M)

1.46% more ownership

Funds ownership: 97.77% → 99.23% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 84 → 79 (-5)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
79
Holders Change
-5
Holders Change %
-5.95%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
34
Reduced
23
Closed
11
Calls
$1.41M
Puts
$1.04M
Net Calls
+$366K
Net Calls Change
+$308K

Top Buyers

Rank Fund Capital Flow
1
ECM
Endurant Capital Management
California
+$3.19M
2
PVI
Pura Vida Investments
New York
+$1.6M
3
SSA
Schonfeld Strategic Advisors
New York
+$891K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$866K
5
Renaissance Technologies
Renaissance Technologies
New York
+$585K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$3.6M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$863K
3
Jennison Associates
Jennison Associates
New York
-$410K
4
PP
Paloma Partners
Connecticut
-$339K
5
BlackRock
BlackRock
New York
-$276K
Name Holding Trade Value Shares
Change 		Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
26
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.35M -$14.7K -2,063 -1%
BCM
27
Bridgeway Capital Management
Texas
$1.26M – – –
Norges Bank
28
Norges Bank
Norway
$1.23M – – –
IP
29
Intellectus Partners
California
$1.02M – – –
Invesco
30
Invesco
Georgia
$979K +$53.7K +7,559 +6%
Deutsche Bank
31
Deutsche Bank
Germany
$956K +$78.3K +11,016 +9%
WMSA
32
Weiss Multi-Strategy Advisers
New York
$936K -$56.9K -8,001 -6%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$899K +$279K +39,300 +49%
Morgan Stanley
34
Morgan Stanley
New York
$857K +$340K +47,793 +72%
JP Morgan Chase
35
JP Morgan Chase
New York
$542K +$453K +63,721 +739%
Charles Schwab
36
Charles Schwab
California
$448K +$36.3K +5,100 +9%
Goldman Sachs
37
Goldman Sachs
New York
$430K +$32.7K +4,593 +9%
TCIM
38
TIAA CREF Investment Management
New York
$428K -$149K -20,978 -27%
TA
39
Teachers Advisors
New York
$422K -$4.52K -636 -1%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$407K – – –
Barclays
41
Barclays
United Kingdom
$380K +$336K +47,250 +1,378%
Wells Fargo
42
Wells Fargo
California
$374K +$6.78K +953 +2%
AllianceBernstein
43
AllianceBernstein
Tennessee
$360K +$17.1K +2,400 +5%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$301K – – –
FC
45
Fairpointe Capital
Illinois
$300K – – –
FAM
46
Fred Alger Management
New York
$285K +$270K +38,000 New
OAM
47
Oxford Asset Management
United Kingdom
$257K -$41.2K -5,793 -15%
PPA
48
Parametric Portfolio Associates
Washington
$246K -$52.6K -7,399 -18%
Citadel Advisors
49
Citadel Advisors
Florida
$245K +$116K +16,356 +100%
Nisa Investment Advisors
50
Nisa Investment Advisors
Missouri
$237K – – –
1
2
3 4

LAB Hedge Fund Activity: Q3 2018 in Review

79 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2018, worth a combined $291M — up 28% from $227M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of LAB and 6 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 34 added.

The largest buyer was Endurant Capital Management, adding an estimated $3.19M. The largest seller was OrbiMed, cutting an estimated $3.6M.

  • 79 institutional investors held Standard BioTools (LAB) as of Q3 2018, down from 84 in Q2 2018.
  • Funds reported $291M of Standard BioTools stock for Q3 2018, up 28% quarter-over-quarter.
  • 6 funds opened new Standard BioTools positions in Q3 2018 and 11 closed out, a net change of -5 holders.
  • The largest Standard BioTools buyer in Q3 2018 was Endurant Capital Management, an estimated $3.19M added.
  • The largest Standard BioTools seller in Q3 2018 was OrbiMed, an estimated $3.6M sold.

Based on aggregated 13F filings for Q3 2018.